Zentalis Pharmaceuticals, Inc. financial data

Symbol
ZNTL on Nasdaq
Location
10275 Science Center Drive, Suite 200, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 745 % -0.51%
Debt-to-equity 28.7 % +12.2%
Return On Equity -51.5 % -17.3%
Return On Assets -40 % -14.4%
Operating Margin -615 % -19.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 72.3M shares +1.38%
Common Stock, Shares, Outstanding 72.2M shares +1.54%
Entity Public Float 232M USD -85.2%
Common Stock, Value, Issued 72K USD +1.41%
Weighted Average Number of Shares Outstanding, Basic 72.1M shares +1.45%
Weighted Average Number of Shares Outstanding, Diluted 72.1M shares +1.45%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 26.9M USD -33.8%
Research and Development Expense 111M USD -40.6%
General and Administrative Expense 69.8M USD +9.99%
Operating Income (Loss) -165M USD +21%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -150M USD +33.6%
Income Tax Expense (Benefit) -205K USD -183%
Net Income (Loss) Attributable to Parent -149M USD +16.7%
Earnings Per Share, Basic -2 USD/shares +14.1%
Earnings Per Share, Diluted -2 USD/shares +14.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 39.1M USD -5.44%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 288M USD -28%
Deferred Income Tax Assets, Net 107K USD
Property, Plant and Equipment, Net 2.93M USD -41.6%
Operating Lease, Right-of-Use Asset 30.2M USD -9.63%
Goodwill 0 USD -100%
Assets 327M USD -27.4%
Accounts Payable, Current 7.03M USD -14.3%
Employee-related Liabilities, Current 8.03M USD -25.8%
Accrued Liabilities, Current 30.1M USD -35.4%
Liabilities, Current 37.2M USD -32.3%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 36.7M USD -9.27%
Other Liabilities, Noncurrent 500K USD -49.8%
Liabilities 74.4M USD -22.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 186K USD -88.3%
Retained Earnings (Accumulated Deficit) -1.16B USD -14.8%
Stockholders' Equity Attributable to Parent 253M USD -28.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 253M USD -28.6%
Liabilities and Equity 327M USD -27.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32.6M USD +37.2%
Net Cash Provided by (Used in) Financing Activities 189K USD +2600%
Net Cash Provided by (Used in) Investing Activities 40.5M USD -34.2%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 72.2M shares +1.54%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.03M USD -16.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 41.7M USD -5.12%
Deferred Tax Assets, Valuation Allowance 247M USD +12.6%
Deferred Tax Assets, Gross 256M USD +11.5%
Operating Lease, Liability 40.5M USD -6.49%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -151M USD +15%
Lessee, Operating Lease, Liability, to be Paid 55.3M USD -10.7%
Property, Plant and Equipment, Gross 5.59M USD -37.7%
Operating Lease, Liability, Current 3.75M USD +33.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.45M USD +2.38%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.28M USD +7.05%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 14.8M USD -20.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.76M USD +4.15%
Deferred Tax Assets, Operating Loss Carryforwards 98.5M USD +1.89%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 14.8M USD +251%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.93M USD +2.19%
Additional Paid in Capital 1.41B USD +3.62%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 899K USD -31.3%
Deferred Tax Assets, Net of Valuation Allowance 8.96M USD -13.6%
Share-based Payment Arrangement, Expense 49M USD -1.65%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%